Qalsody

tofersen

Approval

ApplicationNDA 215887
Approval dateApr 25, 2023
Approval year2023
SponsorBiogen Ma

FDA-approved use

To treat amyotrophic lateral sclerosis in adults who have a SOD1 gene mutation

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Qalsody: